Tissue Microarrays (TMAs)
High-Throughput Validation: Precision-Engineered TMAs for Accelerated Biomarker Discovery
Creative Bioarray provides high-density Tissue Microarrays (TMAs) designed to maximize research efficiency. By assembling hundreds of miniaturized tissue cores onto a single slide, our TMAs enable simultaneous analysis of protein or gene expression across diverse biospecimens under identical experimental conditions, significantly reducing reagent consumption and technical variability.
Product Features
Extensive Cohort Selection
Our portfolio includes multiple cancer types, normal controls, and disease-specific arrays (e.g., neurodegenerative, inflammatory), covering human, NHP, and common laboratory animal models.
Standardized Core Precision
Each TMA is constructed with precise core diameters (typically 0.6mm - 2.0mm) and optimized spacing, ensuring structural integrity and consistent results across IHC, ISH, and FISH applications.
Application-Specific Designs
We offer specialized array formats, including multi-tumor arrays, progression arrays (from normal to metastatic), and custom-configured layouts tailored to your unique study objectives.
Why Choose Our Tissue Microarrays?
Unmatched Statistical Power
- Simultaneous analysis of large cohorts (up to 400+ cores per slide)
- Elimination of slide-to-slide batch effects
- Preservation of limited and precious donor tissues
- Cost-effective screening of experimental therapeutic targets
- High-resolution digital pathology compatible
Verified Clinical Integrity
- Expert pathologist-validated core selection (H&E guided)
- Comprehensive donor clinical data and pathology reports
- Stringent QC for morphology and biomarker antigenicity
- Ethically sourced specimens with full IRB/EC compliance
- Seamless integration with our IHC staining services
A major differentiator of our Tissue Microarray portfolio is the combination of high-density sampling and deep clinical characterization. We ensure that every core represents the specific pathology of interest, providing researchers with a robust platform for statistically significant biomarker validation.
Request a Quote or Custom Solution
Whether you need a validated tumor progression array or a custom-designed TMA featuring specific donor profiles, Creative Bioarray is committed to delivering high-performance solutions backed by technical expertise and ethical sourcing.
Please tell us your target disease indications, required core density, and clinical criteria, and our specialists will help you identify or design the optimal array for your research.
Filters Clear all filters
Species
- Human (742)
- Monkey (7)
- Mouse (16)
- Rat (13)
Source
- Adipose (1)
- Adrenal Gland (2)
- Appendix (2)
- Bladder (6)
- Blood Vessel (1)
- Bone (8)
- Bone Marrow (3)
- Brain (13)
- Breast (16)
- Cartilage (4)
- Cervix (9)
- Colon (116)
- Endometrium (4)
- Esophagus (73)
- Gallbladder (2)
- Heart (7)
- Intestine (160)
- Kidney (24)
- Large Intestine (2)
- Liver (112)
- Lung (48)
- Multiple Organs (82)
- Muscle (3)
- Ovary (8)
- Pancreas (43)
- Penis (5)
- Prostate (11)
- Rectum (42)
- Skin (33)
- Small Intestine (7)
- Smooth Muscle (2)
- Spleen (8)
- Stomach (83)
- Testis (9)
- Thyroid Gland (5)
- Ureter (1)
- Urethra (1)
- Uterus (13)
Disease
- Cancer (696)
- Crohn's Disease (3)
- Gastric Ulcer (4)
- Gastritis (5)
- Hepatitis (8)
- Liver Cirrhosis (17)
- Normal (443)
- Pancreatitis (4)
- Ulcerative Colitis (2)
Description: Colon carcinoma metastatic tissue microarray, containing 220 cases of carcinoma and 8 cases of ...
Description: Colonic carcinoma tissue microarray, containing 16 cases of colon cancer, each in duplicates, with ...
Description: Colon carcinoma tissue microarray, 96 cores including 36 cases of colonic cancers and 12 cases of ...
Description: Colon adenocarcinoma and rectum adenocarcinoma tissue microarray, containing 50 cases of colon ...
Description: Advanced colon adenocarcinoma tissue microarray, with normal adjacent tissue
Description: Colon adenocarcinoma (24 cases) and rectum adenocarcinoma (25 cases), with matched normal adjacent ...
Description: Human esophagus squamous cell carcinoma (Grade I, II and III) and adjacent tissue, 92 cases, single ...
Description: Human esophagus squamous cell carcinoma (Grade II), 30 cases, single core per case. 2 Location ...
Description: Human esophagus squamous cell carcinoma (Grade II-III and III), 32 cases, single core per case.
Description: Human esophagus squamous cell carcinoma (Grade I and I-II) and adjacent tissue, 31 cases, single ...
Description: Human multiple type esophagus carcinoma with adjacent tissue. 21 cases of esophagus carcinoma: 9 ...
Description: Human esophagus squamous cell carcinoma (Grade I and I-II), 45 cases, duplicate cores per cancer.
Description: Human esophagus squamous cell carcinoma and adjacent tissue array, 78 cases of carcinoma and ...
Description: Human esophagus squamous cell carcinoma (Grade I, IIand III) and adjacent tissue, 30 cases, single ...
Description: Human esophagus squamous cell carcinoma (Grade I, IIand III) and adjacent tissue, 75 cases, single ...
Description: Human esophagus squamous cell carcinoma (Grade I-II, II and III), 45 cases, duplicate core per ...
Description: Human esophagus squamous cell carcinoma (Grade I-II, II and III), 40 cases of carcinoma, duplicate ...
Description: Human esophagus squamous cell carcinoma (Grade I, I-II and II), 45 cases, duplicate cores per ...